Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Other Non-Current Assets (2020 - 2023)

Terns Pharmaceuticals' Other Non-Current Assets history spans 4 years, with the latest figure at $35000.0 for Q3 2023.

  • For Q3 2023, Other Non-Current Assets fell 25.53% year-over-year to $35000.0; the TTM value through Sep 2023 reached $35000.0, down 25.53%, while the annual FY2022 figure was $37000.0, 60.64% down from the prior year.
  • Other Non-Current Assets reached $35000.0 in Q3 2023 per TERN's latest filing, down from $36000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $246000.0 in Q4 2020 to a low of $35000.0 in Q3 2023.
  • Average Other Non-Current Assets over 4 years is $98916.7, with a median of $68000.0 recorded in 2022.
  • Peak YoY movement for Other Non-Current Assets: plummeted 72.19% in 2022, then dropped 25.53% in 2023.
  • A 4-year view of Other Non-Current Assets shows it stood at $246000.0 in 2020, then plummeted by 61.79% to $94000.0 in 2021, then tumbled by 60.64% to $37000.0 in 2022, then fell by 5.41% to $35000.0 in 2023.
  • Per Business Quant, the three most recent readings for TERN's Other Non-Current Assets are $35000.0 (Q3 2023), $36000.0 (Q2 2023), and $37000.0 (Q1 2023).